Academic Journal
Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates
| العنوان: | Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates |
|---|---|
| المؤلفون: | Solomon, B., Callejo, A., Bar, J., Berchem, G., Bazhenova, L., Saintigny, P., Raymond, E., Girard, N., Sulaiman, R., Bresson, C., Wunder, F., Lee, J.J., Raynaud, J., Rubin, E., Young, B., Lazar, V., Felip, E., Onn, A., Leyland-Jones, B., Kurzrock, R. |
| المصدر: | Annals of Oncology ; volume 30, page v648 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2019 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/annonc/mdz260.096 |
| الاتاحة: | http://dx.doi.org/10.1093/annonc/mdz260.096 https://api.elsevier.com/content/article/PII:S0923753419597812?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753419597812?httpAccept=text/plain http://academic.oup.com/annonc/article-pdf/30/Supplement_5/mdz260.096/30085582/mdz260.096.pdf |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| رقم الانضمام: | edsbas.D070BF90 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdz260.096 |
|---|